Position in PFE
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$90,238,646
+$11,853,621 QoQ
Shares Held
3,213,627
+2.1% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Dec 31, 2025CallValue
$7,470
CallShares
300
PutValue
$29,880
PutShares
1,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Cetera Investment Advisers holds $1,375,333,185 across 16 Drug Manufacturers - General names. PFE ranks #6 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
345,970 | $318,212,826 | |
| 2 | JNJ |
Johnson & Johnson
|
1,034,600 | $252,897,624 | |
| 3 | ABBV |
AbbVie Inc.
|
965,429 | $209,971,153 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,193,872 | $143,610,862 | |
| 5 | AMGN |
Amgen Inc
|
345,260 | $121,479,731 | |
| 6 | PFE |
Pfizer Inc
This page
|
3,213,627 | $90,238,646 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
404,797 | $56,416,557 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
822,948 | $49,911,796 |
All Filings in PFE
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $90,238,646 | 3,213,627 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $29,880 | 1,200 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $7,470 | 300 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $78,385,025 | 3,147,993 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $75,404,238 | 2,959,350 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $38,220 | 1,500 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $61,279,689 | 2,528,040 | Shares | Sole | 2025-08-08 | |
| 2025-06-30 | $7,272 | 300 | Call | Sole | 2025-08-08 | |
| 2025-03-31 | $59,172,726 | 2,335,151 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $53,632,092 | 2,021,564 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $59,688,402 | 2,062,488 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $59,052,657 | 2,110,531 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $61,107,886 | 2,202,086 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $22,817,773 | 792,559 | Shares | Sole | 2024-02-13 | |
| 2023-12-31 | $287,900 | 10,000 | Call | Sole | 2024-02-13 | |
| 2023-09-30 | $29,089,592 | 876,985 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $30,729,587 | 837,775 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $33,557,347 | 822,484 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $40,407,966 | 788,602 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $27,657,457 | 632,026 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $40,925,232 | 780,569 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $40,323,601 | 778,899 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $11,810 | 200 | Put | Sole | 2022-02-14 | |
| 2021-12-31 | $44,258,152 | 749,503 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $31,919,613 | 742,144 | Shares | Sole | 2021-11-16 | |
| 2021-09-30 | $8,602 | 200 | Put | Sole | 2021-11-16 | |
| 2021-06-30 | $28,122,597 | 718,146 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $24,408,911 | 673,721 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $23,886,597 | 648,916 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $3,662,927 | 105,197 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,087,112 | 99,505 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,265,163 | 73,146 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||